Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Massol

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Therapie|July 10, 2016
[Not Available]Jacques Massol, Myriam Zylberman, Jean-Marie Goehrs, et al.
Therapie|July 10, 2016
[Not Available]Françoise F Homers, Jacques Massol, Patricia Maillère, et al.
Health Policy (Amsterdam, Netherlands)|May 14, 2013
The public health benefit of medicines: how it has been assessed in France? The principles and results of five years' experiencePatrick Maison, Laura Zanetti, Anne Solesse, et al.
Journal of Cancer Policy|September 11, 2024
Is health-related quality of life sufficiently addressed in trials for breast cancer treatments? An assessment based on reimbursement opinions from the French health technology assessment body, 2009-2023Maéva Kyheng, Hélène Tonoli, Nicolas Supah, et al.
Therapie|November 1, 2012
[In Process Citation]François Gueyffier, Catherine Brun Strang, Gilles Berdeaux, et al.
Therapie|November 1, 2012
Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisionsFrançois Gueyffier, Catherine Brun Strang, Gilles Berdeaux, et al.
BMC Nephrology|July 25, 2016
The Non-Dialysis Chronic Renal Insufficiency study (ND-CRIS): an open prospective hospital-based cohort study in FranceJacques Massol, Gérard Janin, Camille Bachot, et al.
BMC Nephrology|February 2, 2017
Pilot non dialysis chronic renal insufficiency study (P-ND-CRIS): a pilot study of an open prospective hospital-based French cohortJacques Massol, Gérard Janin, Camille Bachot, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2012
A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social SecurityLionel Riou França, Chrystelle Vidal, Nadia Bourechak, et al.
Therapie|July 10, 2016
[Not Available]François Gueyffier, Catherine Brun Strang, Gilles Berdeaux, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Therapie|July 10, 2016
[Not Available]Jacques Massol, Myriam Zylberman, Jean-Marie Goehrs, et al.
Therapie|July 10, 2016
[Not Available]Françoise F Homers, Jacques Massol, Patricia Maillère, et al.
Health Policy (Amsterdam, Netherlands)|May 14, 2013
The public health benefit of medicines: how it has been assessed in France? The principles and results of five years' experiencePatrick Maison, Laura Zanetti, Anne Solesse, et al.
Journal of Cancer Policy|September 11, 2024
Is health-related quality of life sufficiently addressed in trials for breast cancer treatments? An assessment based on reimbursement opinions from the French health technology assessment body, 2009-2023Maéva Kyheng, Hélène Tonoli, Nicolas Supah, et al.
Therapie|November 1, 2012
[In Process Citation]François Gueyffier, Catherine Brun Strang, Gilles Berdeaux, et al.
Therapie|November 1, 2012
Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisionsFrançois Gueyffier, Catherine Brun Strang, Gilles Berdeaux, et al.
BMC Nephrology|July 25, 2016
The Non-Dialysis Chronic Renal Insufficiency study (ND-CRIS): an open prospective hospital-based cohort study in FranceJacques Massol, Gérard Janin, Camille Bachot, et al.
BMC Nephrology|February 2, 2017
Pilot non dialysis chronic renal insufficiency study (P-ND-CRIS): a pilot study of an open prospective hospital-based French cohortJacques Massol, Gérard Janin, Camille Bachot, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2012
A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social SecurityLionel Riou França, Chrystelle Vidal, Nadia Bourechak, et al.
Therapie|July 10, 2016
[Not Available]François Gueyffier, Catherine Brun Strang, Gilles Berdeaux, et al.
Pageof 5